BIM Expression in Treatment-Naïve Cancers Predicts Responsiveness to Kinase Inhibitors

Abstract excerpt

Abstract Cancers with specific genetic mutations are susceptible to selective kinase inhibitors. However, there is a wide spectrum of benefit among cancers harboring the same sensitizing genetic mutations. Herein, we measured apoptotic rates among cell lines sharing the same driver oncogene following treatment with the corresponding kinase inhibitor. There was a wide range of kinase inhibitor-induced apoptosis...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Mechanisms and Therapy
• Share to Lung Cancer Treatments and Mutations
• Share to Peptidase Inhibition and Analysis